GSK BHR Study (Sont)

PHASE4CompletedINTERVENTIONAL
Enrollment

464

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Asthma
Interventions
DRUG

Placebo

Twice daily dosing

DRUG

FP 100mcg

Twice daily dosing

DRUG

FP 500mcg

Twice daily dosing

DRUG

FP 250mcg

Twice daily dosing

DRUG

FSC 100/50mcg

Twice daily dosing

DRUG

FSC 250/50mcg

Twice daily dosing

DRUG

FSC 500/50mcg

Twice daily dosing

Trial Locations (58)

2865

GSK Investigational Site, Lincoln

8201

GSK Investigational Site, Absecon

11570

GSK Investigational Site, Rockville Centre

15213

GSK Investigational Site, Pittsburgh

15241

GSK Investigational Site, Pittsburgh

21224

GSK Investigational Site, Baltimore

22908

GSK Investigational Site, Charlottesville

26505

GSK Investigational Site, Morgantown

28625

GSK Investigational Site, Statesville

28801

GSK Investigational Site, Asheville

29407

GSK Investigational Site, Charleston

32610

GSK Investigational Site, Gainesville

33744

GSK Investigational Site, Bay Pines

34233

GSK Investigational Site, Sarasota

35209

GSK Investigational Site, Birmingham

40215

GSK Investigational Site, Louisville

43560

GSK Investigational Site, Sylvania

43617

GSK Investigational Site, Toledo

44718

GSK Investigational Site, Canton

46208

GSK Investigational Site, Indianapolis

47904

GSK Investigational Site, Lafayette

49770

GSK Investigational Site, Petoskey

52242

GSK Investigational Site, Iowa City

55407

GSK Investigational Site, Minneapolis

59701

GSK Investigational Site, Butte

60637

GSK Investigational Site, Chicago

61761

GSK Investigational Site, Normal

68046

GSK Investigational Site, Papillion

70119

GSK Investigational Site, New Orleans

73120

GSK Investigational Site, Oklahoma City

77090

GSK Investigational Site, Houston

80033

GSK Investigational Site, Wheat Ridge

80206

GSK Investigational Site, Denver

80907

GSK Investigational Site, Colorado Springs

85006

GSK Investigational Site, Phoenix

85712

GSK Investigational Site, Tucson

92103

GSK Investigational Site, San Diego

92120

GSK Investigational Site, San Diego

92123

GSK Investigational Site, San Diego

93551

GSK Investigational Site, Palmdale

94598

GSK Investigational Site, Walnut Creek

95117

GSK Investigational Site, San Jose

95128

GSK Investigational Site, San Jose

95608

GSK Investigational Site, Carmichael

97213

GSK Investigational Site, Portland

97223

GSK Investigational Site, Tigard

97504

GSK Investigational Site, Medford

98226

GSK Investigational Site, Bellingham

06106

GSK Investigational Site, Hartford

06611

GSK Investigational Site, Trumbull

08003

GSK Investigational Site, Cherry Hill

37203-1424

GSK Investigational Site, Nashville

41940-060

GSK Investigational Site, Salvador

40110-160

GSK Investigational Site, Porto Alegre

90035 003

GSK Investigational Site, Porto Alegre

LV 1002

GSK Investigational Site, Riga

LV 1003

GSK Investigational Site, Riga

00716

GSK Investigational Site, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00920543 - GSK BHR Study (Sont) | Biotech Hunter | Biotech Hunter